Vertex Pharmaceuticals Incorporated (FRA:VX1)

Vertex Pharmaceuticals Statistics

Total Valuation

FRA:VX1 has a market cap or net worth of EUR 102.83 billion. The enterprise value is 94.10 billion.

Market Cap	102.83B
Enterprise Value	94.10B

Important Dates

The last earnings date was Thursday, February 12, 2026.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	254.03M
Shares Outstanding	n/a
Shares Change (YoY)	+0.04%
Shares Change (QoQ)	-0.58%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	253.21M

Valuation Ratios

The trailing PE ratio is 30.54 and the forward PE ratio is 24.70.

PE Ratio	30.54
Forward PE	24.70
PS Ratio	10.06
PB Ratio	6.47
P/TBV Ratio	7.04
P/FCF Ratio	37.80
P/OCF Ratio	33.25
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 21.69, with an EV/FCF ratio of 34.59.

EV / Earnings	27.95
EV / Sales	9.24
EV / EBITDA	21.69
EV / EBIT	23.65
EV / FCF	34.59

Financial Position

The company has a current ratio of 2.90, with a Debt / Equity ratio of 0.11.

Current Ratio	2.90
Quick Ratio	2.24
Debt / Equity	0.11
Debt / EBITDA	0.40
Debt / FCF	0.64
Interest Coverage	352.44

Financial Efficiency

Return on equity (ROE) is 22.54% and return on invested capital (ROIC) is 29.61%.

Return on Equity (ROE)	22.54%
Return on Assets (ROA)	12.16%
Return on Invested Capital (ROIC)	29.61%
Return on Capital Employed (ROCE)	21.52%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	1.60M
Profits Per Employee	526,084
Employee Count	6,400
Asset Turnover	0.50
Inventory Turnover	3.85

Taxes

In the past 12 months, FRA:VX1 has paid 587.67 million in taxes.

Income Tax	587.67M
Effective Tax Rate	14.86%

Stock Price Statistics

The stock price has decreased by -8.70% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-8.70%
50-Day Moving Average	393.40
200-Day Moving Average	373.44
Relative Strength Index (RSI)	53.46
Average Volume (20 Days)	61

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.03

Income Statement

In the last 12 months, FRA:VX1 had revenue of EUR 10.22 billion and earned 3.37 billion in profits. Earnings per share was 13.05.

Revenue	10.22B
Gross Profit	5.49B
Operating Income	3.99B
Pretax Income	3.95B
Net Income	3.37B
EBITDA	4.14B
EBIT	3.99B
Earnings Per Share (EPS)	13.05

Balance Sheet

The company has 5.63 billion in cash and 1.73 billion in debt, with a net cash position of 8.76 billion.

Cash & Cash Equivalents	5.63B
Total Debt	1.73B
Net Cash	8.76B
Net Cash Per Share	n/a
Equity (Book Value)	15.90B
Book Value Per Share	62.59
Working Capital	6.25B

Cash Flow

In the last 12 months, operating cash flow was 3.09 billion and capital expenditures -372.70 million, giving a free cash flow of 2.72 billion.

Operating Cash Flow	3.09B
Capital Expenditures	-372.70M
Free Cash Flow	2.72B
FCF Per Share	n/a

Margins

Gross margin is 53.67%, with operating and profit margins of 39.06% and 32.94%.

Gross Margin	53.67%
Operating Margin	39.06%
Pretax Margin	38.69%
Profit Margin	32.94%
EBITDA Margin	40.55%
EBIT Margin	39.06%
FCF Margin	26.61%

Dividends & Yields

FRA:VX1 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.04%
Shareholder Yield	-0.04%
Earnings Yield	3.27%
FCF Yield	2.65%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:VX1 has an Altman Z-Score of 11.93 and a Piotroski F-Score of 6.

Altman Z-Score	11.93
Piotroski F-Score	6